Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | XDH | P47989 | 2/20 | 0.43 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | STK10 | O94804 | 1/20 | 0.40 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.40 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10051180 | 0.89 | ADRA2C (0.49) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10051189 | 0.88 | CYP1A2 (0.49) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL26750958 | 0.88 | CYP1A2 (0.49) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL26754072 | 0.87 | PIM1 (0.53) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10296082 | 0.84 | CYP1A2 (0.51) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL22360100 | 0.83 | CA1 (0.51) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL15856498 | 0.83 | GRM5 (0.47) | MCL1PIM1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL19939359 | 0.83 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19ALOX15 | |
| SCHEMBL26754199 | 0.82 | CA1 (0.44) | MCL1CYP1A2CA1CA2XDH | |
| SCHEMBL6278115 | 0.82 | MCL1 (0.43) | MCL1PIM1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2012021315-A2 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120187383-A1 | ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | CCNL2, ESR1, ESR2 | MCL1 3879/4885PIM1 1069/4885CYP1A2 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.